Latest Mergers And Acquisitions News

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Resolution Minerals Ltd has responded to an ASX price query following a significant jump in its share price and trading volume, confirming no undisclosed material information. The company attributes the surge to sector-wide momentum and recent diplomatic engagements.

Ionic Rare Earths has expanded its capital raising to $15.6 million, driven by a $3 million strategic investment from US firm Argentem Creek Partners and strong shareholder support. The funds will accelerate projects across magnet recycling, rare earth refining, and US supply chain development.

Bannerman Energy reports solid progress at its Etango Uranium Project, securing initial offtake agreements and maintaining robust financial health as it targets a Final Investment Decision within the next year.

Hazer Group has received a $4.58 million R&D tax incentive refund for FY25, reinforcing its financial position as it advances its methane pyrolysis technology towards commercialisation.

Bannerman Energy Ltd reported a robust cash position of AUD 111.76 million at the end of September 2025, underpinning an estimated 13.5 quarters of operational funding despite ongoing exploration expenditures.

ARB Corporation Limited reported a 5.3% increase in FY25 sales revenue to A$729.9 million, driven by strong export growth and strategic US market moves, despite a 5% dip in profit after tax.

Orezone Gold Corporation reported solid Q3-2025 gold production amid weather challenges and is on track to commission its stage 1 hard rock expansion at Bomboré, aiming for a significant production increase next year.

Power Minerals Limited (PNN) has been invited to brief the Australian Ambassador to the US on its strategic Gamma Heavy Rare Earths Project in California, underscoring the project's growing importance in Australia-US critical minerals cooperation ahead of the Prime Minister's meeting with President Trump.

Aroa Biosurgery delivered a robust September quarter with strong cash flow and record sales of its Myriad product, while reaffirming its FY26 revenue and EBITDA guidance. The company also highlighted a promising US Medicare reimbursement proposal for its Symphony product.

Native Mineral Resources Holdings Limited reported a challenging quarter with negative operating cash flow but secured significant financing to support ongoing exploration activities. The company anticipates improved cash flow performance in coming months.